Patents by Inventor Dongqin WANG

Dongqin WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230357268
    Abstract: Disclosed is a tricyclic pyrimidinone compound of Formula (I) or a pharmaceutically acceptable salt thereof, which is a novel Lp-PLA2 inhibitor useful in treating neurodegeneration-related diseases such as Alzheimer's disease (AD), glaucoma and age-related macular degeneration (AMD), or cardiovascular diseases including atherosclerosis.
    Type: Application
    Filed: July 6, 2021
    Publication date: November 9, 2023
    Inventors: Zhenghua GU, Dongqin WANG, Youhong HU
  • Publication number: 20230271980
    Abstract: Disclosed is a tricyclic pyrimidinone compound of Formula (I) or a pharmaceutically acceptable salt thereof, which is an entirely new Lp-PLA2 inhibitor useful in treating neurodegeneration-related diseases such as Alzheimer's disease (AD), glaucoma and age-related macular degeneration (AMD), or cardiovascular diseases including atherosclerosis.
    Type: Application
    Filed: June 25, 2021
    Publication date: August 31, 2023
    Inventors: Zhenghua GU, Dongqin WANG, Youhong HU
  • Publication number: 20230212168
    Abstract: Disclosed is an endocyclic pyrimidinone compound of Formula (I) or a pharmaceutically acceptable salt thereof, which is an entirely new Lp-PLA2 inhibitor useful in treating neurodegeneration-related diseases such as Alzheimer's disease (AD), glaucoma and age-related macular degeneration (AMD), or cardiovascular diseases including atherosclerosis.
    Type: Application
    Filed: May 12, 2021
    Publication date: July 6, 2023
    Inventors: Zhenghua GU, Dongqin WANG